Astralith
astra, Latin for stars · lithos, Greek for stone
A star set in stone.
Four stones: records that are only ever added to, never rewritten.The star: the decision a person signs once the evidence is in place.
Astralith builds software for the two moments that decide whether a trial can be relied on: when the protocol is written, and while the study runs.
What we
believe
The decisions that make a trial analyzable are made before it starts, in documents and meetings that leave no record. The data that makes a trial believable is captured while it runs, too often on paper first.
We think both moments deserve software that refuses: refuses to overwrite, refuses to let a model decide, refuses to export what a person has not signed. Software proposes. Rules decide. A person signs.
Who builds it
Rakesh Muppa
Founder & CEO
Building software that makes clinical evidence hold up, from the first protocol draft to the locked dataset.
Rakesh founded Astralith and designed and built both of its products: Antevra, which shows what a protocol can support before anyone commits to it, and Actora, which runs BE/BA studies on a record built for inspection. Rakesh leads product and engineering at Astralith.
“The parts I am most confident about are the refusals: no override on the export gate, no faked validation, no invented citation left unmarked.”Rakesh on LinkedIn (opens in a new tab)
Advisors from clinical operations, biostatistics and QA will be listed here as they join.
Talk to the people who build it
Book a 30-minute call, or write to [email protected].
Book 30 minutes (opens in a new tab)